Method of calibrating an analyte-measurement device, and associated methods, devices and systems

• US 8,219,175 B2
• Filed: 06/29/2009
• Issued: 07/10/2012
• Est. Priority Date: 10/31/2003
• Status: Expired due to Fees

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Feldman, Benjamin J., McGarraugh, Geoffrey V.
• Primary Examiner(s): Natnithithadha, Navin
• Application Number:
  US12/494,221
• Publication Number:
  US 20090265130A1
• Time in Patent Office: 1,107 Days
• Field of Search: 600/309, 600345-366
• US Class Current: 600/347
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/0024 for multiple sensor units attached to the patient, e.g. using a body or personal area network
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/6898 Portable consumer electronic devices, e.g. music players, telephones, tablet computers
• CPC Class Codes: A61B 5/7246 using correlation, e.g. template matching or determination of similarity
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61B 5/746 Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms alarms per se G08B
• CPC Class Codes: A61B 5/7475 User input or interface means, e.g. keyboard, pointing device, joystick

Abstract

The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.

Claims

1. An in vivo glucose sensor calibration system, comprising:

at least one analyte sensor including one or more working electrodes each including a portion which is subcutaneously positioned to generate one or more signals associated with a monitored glucose level;

a calibration sensor configured to be placed in contact with a blood sample from an off-finger calibration site to provide a calibration measurement; and

one or more processors operatively coupled to one or more of the one or more working electrodes or the calibration sensor, the one or more processors configured to compare the generated one or more signals from the one or more working electrodes to determine if the one or more signals differ by a predetermined threshold amount, to convert the one or more signals to a glucose concentration level using the calibration measurement based on the comparison, to determine a sensitivity of the at least one analyte sensor, and to determine a temperature compensated glucose concentration by dividing at least one value of the one or more signals by the sensitivity value and multiplying by a temperature compensation factor that is raised to a power equal to the difference in the temperature at a time associated with a calibration point and the temperature at the time associated with the generated one or more signals.

2. The system of claim 1, wherein the one or more processors is configured to not perform the conversion if the one or more signals differ by the predetermined threshold amount.

3. The system of claim 1, wherein the one or more processors is configured to perform the conversion if the one or more signals differ by less than the predetermined threshold amount.

4. The system of claim 3, wherein the sensitivity is determined based at least in part on the one or more signals from the one or more working electrodes and the calibration measurement.

5. The system of claim 4, wherein the sensitivity is an unweighted sensitivity factor.

6. The system of claim 4, wherein the sensitivity is a weighted sensitivity factor.

7. The system of claim 1, wherein the each of the one or more working electrodes comprises a sensing element that comprises a hydrophilic portion.

8. The system of claim 1, comprising a hand-held display module.

9. The system of claim 1, wherein the one or more processors is configured to evaluate whether the calibration measurement is within a predetermined range of analyte concentration when determining the quality of the calibration measurement.

10. The system of claim 9, wherein the predetermined range of analyte concentration comprises about 60 mg/dL to about 350 mg/dL.

11. The system of claim 1, wherein the calibration sensor is an in vitro sensor.

12. The system of claim 1, wherein the calibration sensor is an in vivo calibration sensor.

13. The system of claim 1, wherein the predetermined range of sensitivity is determined during the manufacturing process of the at least one analyte sensor.

14. The system of claim 1, wherein the system determines the predetermined range of sensitivity by evaluating a code associated with the at least one analyte sensor.

15. The system of claim 1, wherein the one or more processors is configured to evaluate that a temperature measurement is within a predetermined range of temperatures when determining the quality of the calibration measurement.

16. The system of claim 1, wherein the one or more processors is configured to evaluate that a predetermined time period has elapsed since an implantation of the at least one analyte sensor when determining the quality of the calibration measurement.

17. The system of claim 1, wherein the one or more processors is configured to evaluate that a predetermined time period has elapsed since a prior calibration measurement when determining the quality of the calibration measurement.

18. The system of claim 1, wherein the one or more processors is configured to evaluate a quality of the calibration measurement by comparing the determined sensitivity of the at least one analyte sensor to a predetermined range.

19. The system of claim 1, wherein the one or more processors is configured to determine a lag corrected glucose concentration by adding to the determined temperature compensated glucose concentration a lag correction factor that is multiplied by a change in the temperature compensated glucose concentration divided by a time period between two calibration measurements minus the temperature divided by the change in time between the two calibration measurements.